Healios K.K.
Research Healios K.K. (4593.T) on Bullrun: market cap JPY 37.94B, P/E 270.2. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- Ticker4593.T
- ExchangeTSE
- CountryJapan
- SectorHealthcare
- IndustryBiotechnology
- CurrencyJPY
- Market capJPY 37.94B
- P/E270.2
- Financial periodFY2025
- RevenueJPY 104.00M
- Revenue growth-81.4%
- Net income-JPY 2.22B
- Free cash flow-JPY 3.33B
- Gross margin-109.6%
Valuation Snapshot
latest market cap is JPY 37.94B; P/E is 270.2.
Peer valuation comparison
Latest P/E is 270.19x versus a Healthcare sector median of 21.69x (1145.6% above).
Latest P/E is 270.19x versus a Japan median of 14.28x (1792.7% above).
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | JPY 104.00M | -JPY 2.22B | -JPY 3.33B | -109.6% | -26.6 | JPY 5.68B | JPY 2.61B | JPY 4.89B |
| FY2024 | JPY 560.00M | -JPY 4.24B | -JPY 2.12B | 77.1% | -47.86 | JPY 3.67B | JPY 2.66B | JPY 2.06B |
| FY2023 | JPY 121.00M | -JPY 3.82B | -JPY 2.85B | 90.1% | -56.22 | JPY 6.72B | JPY 4.53B | JPY 3.86B |
| FY2022 | JPY 90.00M | -JPY 5.17B | -JPY 4.86B | 100.0% | -90.67 | JPY 7.25B | JPY 7.15B | JPY 4.38B |
| FY2021 | n/a | n/a | n/a | n/a | -99.51 | n/a | n/a | n/a |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-18 | JPY 37.94B | 270.2 | n/a | 0 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 0 JPY.
About Healios K.K.
Healios K.K., together with its subsidiaries, engages in the research, development, manufacturing, and sale of cell therapy and regenerative medicine products in Japan, Europe, and the United States. The company offers HLCM051, which is preparing for approval for the treatment of acute respiratory distress syndrome; HLCM051, which is preparing for phase 3 clinical trial for the treatment of ischemic stroke;
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Healios K.K.'s market cap?
Healios K.K.'s market capitalization is JPY 37.94B.
What is Healios K.K.'s P/E ratio?
Healios K.K.'s price-to-earnings (P/E) ratio is 270.2.
What does Healios K.K. do?
Healios K.K., together with its subsidiaries, engages in the research, development, manufacturing, and sale of cell therapy and regenerative medicine products in Japan, Europe, and the United States.